Peter Ellinghaus

4.1k citations

74 papers · 3.1k indexed · h-index 28

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Biochemistry top 2%

Papers in ⓘ

Cancer Research 18
- Cancer, Hypoxia, and Metabolism 14
- Cancer, Lipids, and Metabolism 5
Rheumatology 11
- Eosinophilic Disorders and Syndromes 11

Co-authors: Udo Seedorf (10 shared papers)Gerd Assmann (7 shared papers)Ingo Flamme (4 shared papers)Friedrich Spener (5 shared papers)Christian Wolfrum (5 shared papers)Khusru Asadullah (2 shared papers)Anette Sommer (2 shared papers)Isabella Gashaw (2 shared papers)
Journals: Cancer Research (10 papers)Journal of Clinical Oncology (8 papers)Annals of Oncology (4 papers)Journal of Biological Chemistry (3 papers)Physiological Genomics (3 papers)
Partner nations: Germany United States Spain

In The Last Decade

Peter Ellinghaus

72 papers receiving 3.0k citations

Peers

Countries citing papers authored by Peter Ellinghaus

Since Specialization

Citations

This map shows the geographic impact of Peter Ellinghaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellinghaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellinghaus more than expected).

Fields of papers citing papers by Peter Ellinghaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ellinghaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellinghaus. The network helps show where Peter Ellinghaus may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Ellinghaus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Ellinghaus Line = papers co-authored together Peter Ellinghaus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function Genes & Development ·U. Seedorf, M. Raabe, Peter Ellinghaus, Frank Kannenberg, Manfred Fobker, Thomas Engel, S. Denis, Fred S. Wouters, K. W.A. Wirtz, R. J. A. Wanders, Nobuaki Maeda, G. Assmann	1998	228
2	Novel Aspects of Fibrin(ogen) Fragments during Inflammation Molecular Medicine ·Carla Jennewein, Nguyen Tran, Patrick Paulus, Peter Ellinghaus, Johannes A. Eble, Kai Zacharowski	2011	188
3	BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I Cancer Medicine ·Peter Ellinghaus, Iring Heisler, Kerstin Unterschemmann, Michael Haerter, Hartmut Beck, Susanne Greschat, Alexander Ehrmann, Holger Summer, Ingo Flamme, Felix Oehme, Karl‐Heinz Thierauch, Martin Michels, Holger Hess‐Stumpp, Karl Ziegelbauer	2013	179
4	What makes a good drug target? Drug Discovery Today ·Isabella Gashaw, Peter Ellinghaus, Anette Sommer, Khusru Asadullah	2011	160
5	Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor α (PPARα) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice Journal of Biological Chemistry ·Peter Ellinghaus, Christian Wolfrum, Gerd Assmann, Friedrich Spener, Udo Seedorf	1999	149
6	Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects PLoS ONE ·Ingo Flamme, Felix Oehme, Peter Ellinghaus, Mario Jeske, Jörg Keldenich, Uwe Thuß	2014	139
7	Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors Biochemical and Biophysical Research Communications ·Felix Oehme, Peter Ellinghaus, Peter Kolkhof, Timothy J. Smith, S Ramakrishnan, Joachim Hütter, Matthias Schramm, Ingo Flamme	2002	133
8	Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices The Journal of Heart and Lung Transplantation ·Hendrik Milting, Peter Ellinghaus, Michael J. Seewald, Hamdin Cakar, Birte Bohms, Astrid Kassner, Reiner Körfer, Martina I. Klein, Thomas Krahn, Lothar Kruska, Aly El Banayosy, Frank Kramer	2008	125
9	Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders Cardiovascular Diabetology ·Wilfried Dinh, Reiner Füth, Werner Nickl, Thomas Krahn, Peter Ellinghaus, Thomas Scheffold, Lars Bansemir, Alexander Bufe, Michael Coll Barroso, Mark Lankisch	2009	121
10	Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling Circulation ·Martina I. Klein, Ralph T. Schermuly, Peter Ellinghaus, Hendrik Milting, Bernd Riedl, Sevdalina Nikolova, Soni Savai Pullamsetti, Norbert Weißmann, Eva Dony, Rajkumar Savai, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Andreas Büsch, Stefan Schäfer	2008	120
11	Sterol carrier protein-2 Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Udo Seedorf, Peter Ellinghaus, Jerzy Roch Nofer	2000	119
12	Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein Journal of Lipid Research ·Christian Wolfrum, Peter Ellinghaus, Manfred Fobker, Udo Seedorf, Gerd Assmann, Torsten Börchers, Friedrich Spener	1999	113
13	Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer International Journal of Cancer ·Roberta Schmieder, Jens Hoffmann, Michael W. Becker, Ajay Bhargava, Tina Müller, Nicole Kahmann, Peter Ellinghaus, Robert Adams, André Rosenthal, Karl‐Heinz Thierauch, Arne Scholz, Scott M. Wilhelm, Dieter Zopf	2013	103
14	Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays Journal of Thoracic and Cardiovascular Surgery ·Peter Ellinghaus, Robert Scheubel, Dobromir Dobrev, Ursula Ravens, Juergen Holtz, Joachim Huetter, Ulrich Nielsch, Henning Morawietz	2005	92
15	Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models International Journal of Cancer ·Sylvia Grünewald, Oliver Politz, Sebastian Bender, Mélanie Héroult, Klemens Lustig, Uwe Thuß, Christoph Kneip, Charlotte Kopitz, Dieter Zopf, Marie-Pierre L. Collin, Ulf Boemer, Stuart Ince, Peter Ellinghaus, Dominik Mumberg, Holger Hess‐Stumpp, Karl Ziegelbauer	2019	72
16	Aberrant Oxidation of the Cholesterol Side Chain in Bile Acid Synthesis of Sterol Carrier Protein-2/Sterol Carrier Protein-x Knockout Mice Journal of Biological Chemistry ·Frank Kannenberg, Peter Ellinghaus, Gerd Assmann, Udo Seedorf	1999	67
17	What makes a good drug target? Drug Discovery Today ·Isabella Gashaw, Peter Ellinghaus, Anette Sommer, Khusru Asadullah	2011	65
18	FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase PLoS ONE ·Ingo Flamme, Peter Ellinghaus, Diana Urrego, Thilo Krüger	2017	62
19	Branched Chain Fatty Acids Induce Nitric Oxide-dependent Apoptosis in Vascular Smooth Muscle Cells Journal of Biological Chemistry ·Susanne Idel, Peter Ellinghaus, Christian Wolfrum, Jerzy–Roch Nofer, Jolein Gloerich, Gerd Assmann, Friedrich Spener, Udo Seedorf	2002	60
20	Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran Thrombosis Research ·Peter Ellinghaus, Elisabeth Perzborn, Peter Hauenschild, Christoph Gerdes, Stefan Heitmeier, Mayken Visser, Holger Summer, Volker Laux	2016	60

About Peter Ellinghaus

Peter Ellinghaus is a scholar working on Cancer Research, Rheumatology, Molecular Biology, Surgery and Hematology, having authored 74 papers that have together received 3.1k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (24 papers), Cancer, Hypoxia, and Metabolism (14 papers), Bladder and Urothelial Cancer Treatments (12 papers), Eosinophilic Disorders and Syndromes (11 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Pulmonary Hypertension Research and Treatments (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Kruppel-like factors research (5 papers). The work is most often cited by research in Cancer Research (544 citations), Biochemistry (199 citations), Clinical Biochemistry (170 citations), Molecular Biology (1.6k citations) and Hematology (245 citations). Peter Ellinghaus has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Udo Seedorf, Gerd Assmann, Ingo Flamme, Friedrich Spener, Christian Wolfrum, Khusru Asadullah, Anette Sommer, Isabella Gashaw, Felix Oehme and Frank Kannenberg. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Journal of Biological Chemistry and Physiological Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact